Tekla Capital Management LLC - ASCENDIS PHARMA A/S ownership

ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 164 filers reported holding ASCENDIS PHARMA A/S in Q3 2023. The put-call ratio across all filers is 1.12 and the average weighting 0.6%.

Quarter-by-quarter ownership
Tekla Capital Management LLC ownership history of ASCENDIS PHARMA A/S
ValueSharesWeighting
Q2 2023$12,387,097
-6.7%
138,791
+12.1%
0.48%
-4.0%
Q1 2023$13,272,871
-12.2%
123,7910.0%0.50%
-11.6%
Q4 2022$15,118,595
+116.0%
123,791
+82.6%
0.57%
+99.0%
Q3 2022$7,000,000
+11.1%
67,7940.0%0.29%
+15.7%
Q2 2022$6,302,000
-20.8%
67,7940.0%0.25%
-11.1%
Q1 2022$7,956,000
-12.8%
67,7940.0%0.28%
-4.8%
Q4 2021$9,120,000
-15.6%
67,7940.0%0.29%
-15.8%
Q3 2021$10,806,000
-46.5%
67,794
-55.9%
0.35%
-47.0%
Q2 2021$20,211,000
+32.5%
153,636
+29.8%
0.66%
+25.1%
Q1 2021$15,251,000
-5.0%
118,336
+23.0%
0.52%
-6.9%
Q4 2020$16,052,000
-17.3%
96,246
-23.5%
0.56%
-22.4%
Q3 2020$19,405,000
+128.2%
125,746
+118.8%
0.73%
+124.4%
Q2 2020$8,502,000
+8.9%
57,482
-17.1%
0.32%
-8.2%
Q1 2020$7,807,000
-19.1%
69,3320.0%0.35%
-3.3%
Q4 2019$9,645,000
+29.8%
69,332
-10.2%
0.36%
+12.7%
Q3 2019$7,433,000
-12.3%
77,167
+4.8%
0.32%
-6.4%
Q2 2019$8,480,000
+17.4%
73,647
+20.0%
0.35%
+18.1%
Q1 2019$7,222,000
+171.9%
61,360
+44.7%
0.29%
+157.0%
Q4 2018$2,656,000
-43.0%
42,399
-35.5%
0.11%
-32.5%
Q3 2018$4,656,000
+59.4%
65,714
+49.6%
0.17%
+52.3%
Q2 2018$2,921,000
+619.5%
43,914
+606.7%
0.11%
+593.8%
Q1 2018$406,0006,2140.02%
Other shareholders
ASCENDIS PHARMA A/S shareholders Q3 2023
NameSharesValueWeighting ↓
RA Capital Management 7,387,900$1,177,557,00016.32%
Q Global Advisors, LLC 66,714$10,634,0008.85%
Ghost Tree Capital, LLC 120,000$19,127,0005.59%
Vivo Capital, LLC 760,606$121,233,0005.44%
Spyglass Capital Management LLC 1,378,887$219,781,0005.04%
Avoro Capital Advisors LLC 1,980,000$315,592,0004.96%
Eversept Partners, LP 445,203$70,960,9064.93%
Sofinnova Investments, Inc. 499,824$79,667,0004.72%
Eventide Asset Management 1,748,648$278,717,0003.68%
Baker Brothers Advisors 4,541,604$723,886,0003.18%
View complete list of ASCENDIS PHARMA A/S shareholders